Showing results (71-80 of 125) with videos related to
Sort By:
Pageof 13
The Journal of Biological Chemistry|November 8, 2005
Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressantsL Keith Henry, Julie R Field, Erika M Adkins, et al.The Lancet. HIV|October 2, 2015
Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b studyJean-Michel Molina, Bonaventura Clotet, Jan van Lunzen, et al.AIDS Patient Care and Stds|May 24, 2007
Demographic, clinical, and virologic characteristics of African-born persons with HIV/AIDS in a Minnesota hospitalOmobosola O Akinsete, Tracy Sides, Diane Hirigoyen, et al.Journal of the International AIDS Society|November 14, 2014
Once-daily dolutegravir is superior to once-daily darunavir/ritonavir in treatment-naïve HIV-1-positive individuals: 96 week results from FLAMINGOJean-Michel Molina, Bonaventura Clotet, Jan van Lunzen, et al.Nature Communications|January 26, 2016
Membrane potential shapes regulation of dopamine transporter trafficking at the plasma membraneBen D Richardson, Kaustuv Saha, Danielle Krout, et al.AIDS (London, England)|August 28, 2007
Risk of cancers during interrupted antiretroviral therapy in the SMART studyMichael J Silverberg, Jacqueline Neuhaus, Mark Bower, et al.ACS Chemical Neuroscience|January 23, 2019
Human Serotonin Transporter Coding Variation Establishes Conformational Bias with Functional ConsequencesMeagan A Quinlan, Danielle Krout, Rania M Katamish, et al.AIDS (London, England)|April 23, 2008
CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infectionJason V Baker, Grace Peng, Joshua Rapkin, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|July 23, 2008
Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseasesJason V Baker, Grace Peng, Joshua Rapkin, et al.AIDS (London, England)|May 21, 2005
Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposureJudith S Currier, Michelle A Kendall, Robert Zackin, et al.Pageof 13